Last 48 quarters of trend data · Healthcare · Specialty & Generic Drugs
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -1.25 | — | 4.69 | — | — | 99.31 | — | — | — | — | — | 804.75 | — | 72.61 | 130.18 | — | — | — | — | — | 40.52 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.54 | 0.54 | 0.34 | 0.34 | 0.43 | 0.71 | 0.87 | 0.93 | 0.78 | 0.81 | 0.83 | 1.02 | 0.94 | 0.97 | 0.97 | 1.02 | 0.99 | 1.09 | 1.23 | 1.19 | 1.18 |
| — | -23.9% | -60.9% | -63.2% | -44.1% | -11.9% | +5.1% | -9.6% | -17.5% | -16.7% | -15.0% | -0.0% | -5.2% | -10.8% | -21.0% | -14.3% | -15.5% | -30.0% | -22.9% | -11.9% | -0.3% | |
| P/B Ratio | 0.75 | 0.88 | 0.55 | 0.53 | 0.66 | 0.67 | 0.82 | 0.89 | 0.82 | 0.77 | 0.77 | 0.95 | 0.91 | 0.92 | 0.96 | 1.00 | 0.95 | 1.04 | 1.14 | 1.01 | 1.01 |
| — | +31.5% | -32.7% | -40.3% | -19.8% | -13.3% | +5.9% | -6.3% | -10.4% | -16.3% | -19.0% | -5.6% | -3.6% | -11.5% | -16.0% | -0.5% | -6.0% | -16.8% | +0.1% | +2.1% | -6.2% | |
| P/FCF | 9.80 | 6.83 | 2.80 | — | 3.24 | 25.00 | 16.17 | — | 3.22 | 58.39 | — | — | 5.99 | 11.80 | 35.24 | — | 7.20 | 31.66 | — | 21.83 | — |
| — | -72.7% | -82.7% | — | +0.8% | -57.2% | — | — | -46.3% | +395.0% | — | — | -16.8% | -62.7% | — | — | — | +488.3% | — | — | — | |
| EV / EBITDA | 9.96 | 11.91 | 5.29 | 10.15 | 9.55 | 10.08 | 13.38 | 13.96 | 8.48 | 10.48 | 31.77 | 74.84 | 27.32 | 13.12 | 13.86 | 15.62 | 16.23 | 17.36 | 29.87 | 18.32 | 14.63 |
| — | +18.1% | -60.5% | -27.3% | +12.7% | -3.7% | -57.9% | -81.3% | -69.0% | -20.2% | +129.2% | +379.1% | +68.3% | -24.4% | -53.6% | -14.8% | +11.0% | +345.8% | — | +21.3% | -69.5% | |
| EV / EBIT | 16.40 | 63.08 | 7.45 | — | — | 20.86 | 41.16 | 37.43 | 14.58 | 21.47 | — | — | — | 32.04 | 31.42 | 44.65 | 78.16 | 56.28 | — | 73.30 | 43.48 |
| — | +202.4% | -81.9% | — | — | -2.8% | — | — | — | -33.0% | — | — | — | -43.1% | — | -39.1% | +79.8% | +1085.9% | — | +67.7% | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 35.1% | 32.4% | 30.7% | 33.6% | 32.6% | 36.1% | 34.4% | 37.6% | 33.9% | 37.2% | 37.0% | 33.1% | 36.9% | 36.6% | 35.9% | 35.0% | 33.1% | 33.0% | 33.2% | 31.4% | 32.8% |
| — | -10.2% | -10.7% | -10.6% | -3.7% | -2.8% | -7.3% | +13.7% | -8.2% | +1.6% | +3.3% | -5.6% | +11.5% | +10.9% | +8.1% | +11.4% | +1.0% | +2.2% | -6.7% | -13.8% | -9.9% | |
| Operating Margin | 8.1% | 2.3% | 2.3% | 3.5% | 7.6% | 7.0% | 4.3% | 4.5% | 10.0% | 7.4% | -2.5% | -5.1% | -1.3% | 5.5% | 4.8% | 4.1% | 2.7% | 3.0% | -0.6% | 2.0% | 4.2% |
| — | -66.4% | -46.5% | -21.5% | -23.9% | -5.9% | +272.8% | +188.1% | +844.0% | +33.8% | -152.2% | -224.3% | -150.3% | +83.7% | +874.0% | +103.2% | -36.5% | -92.8% | +95.2% | -60.3% | +204.4% | |
| Net Margin | -33.5% | -2.8% | 7.3% | -41.1% | -127.8% | 0.7% | -0.8% | -0.6% | -3.9% | -1.9% | -10.2% | 0.2% | -2.8% | 1.3% | 0.7% | -0.3% | -2.1% | -4.5% | -5.8% | -0.2% | 0.9% |
| — | -486.9% | +1016.0% | -6608.0% | -3169.2% | +137.2% | +92.2% | -431.8% | -40.0% | -252.8% | -1545.1% | +172.8% | -36.1% | +128.1% | +112.1% | -13.7% | -336.1% | +20.5% | +1.3% | -105.9% | +106.4% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -39.3% | -1.1% | 3.0% | -14.7% | -38.4% | 0.2% | -0.2% | -0.1% | -1.0% | -0.5% | -2.3% | 0.0% | -0.7% | 0.3% | 0.2% | -0.1% | -0.5% | -1.0% | -1.3% | -0.0% | 0.2% |
| — | -759.8% | +1663.0% | -9852.4% | -3735.9% | +136.5% | +91.9% | -448.5% | -47.4% | -255.6% | -1453.5% | +168.2% | -35.4% | +128.3% | +113.3% | -32.5% | -370.1% | +5.1% | -25.5% | -106.9% | +106.1% | |
| ROA | -15.7% | -0.4% | 1.0% | -4.8% | -15.2% | 0.1% | -0.1% | -0.1% | -0.4% | -0.2% | -1.0% | 0.0% | -0.3% | 0.1% | 0.1% | -0.0% | -0.2% | -0.5% | -0.6% | -0.0% | 0.1% |
| — | -590.4% | +1229.6% | -7212.3% | -3469.0% | +138.2% | +91.8% | -454.8% | -42.5% | -248.7% | -1445.3% | +168.1% | -37.1% | +128.6% | +112.5% | -18.2% | -342.8% | +14.0% | -19.4% | -106.9% | +105.9% | |
| ROIC | 3.7% | 0.3% | 0.3% | 0.4% | 0.9% | 0.7% | 0.4% | 0.5% | 1.1% | 0.8% | -0.2% | -0.5% | -0.1% | 0.5% | 0.5% | 0.4% | 0.3% | 0.3% | -0.1% | 0.2% | 0.5% |
| — | -53.3% | -29.7% | -11.4% | -20.5% | -8.4% | +279.5% | +191.9% | +892.3% | +38.0% | -149.5% | -220.4% | -151.3% | +85.0% | +826.9% | +77.9% | -46.2% | -93.0% | +93.7% | -46.1% | +213.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.35 | 1.35 | 1.31 | 1.52 | 1.35 | 0.86 | 0.86 | 0.83 | 0.84 | 1.04 | 0.89 | 0.87 | 0.85 | 0.90 | 0.88 | 0.89 | 0.89 | 0.89 | 0.85 | 0.69 | 0.72 |
| — | +56.3% | +52.8% | +83.2% | +61.4% | -17.3% | -4.0% | -4.2% | -2.0% | +15.8% | +1.3% | -2.2% | -4.3% | +0.7% | +3.9% | +28.8% | +24.6% | +30.4% | +31.6% | +7.5% | +8.8% | |
| Debt / EBITDA | 5.83 | 31.29 | 16.26 | 32.39 | 28.27 | 24.22 | 29.10 | 28.61 | 18.60 | 29.22 | 73.24 | 155.17 | 57.94 | 27.82 | 28.36 | 31.24 | 33.76 | 33.81 | 53.75 | 38.54 | 30.76 |
| — | +29.2% | -44.1% | +13.2% | +52.0% | -17.1% | -60.3% | -81.6% | -67.9% | +5.0% | +158.2% | +396.7% | +71.6% | -17.7% | -47.2% | -18.9% | +9.8% | +387.4% | — | +53.5% | -60.5% | |
| Current Ratio | 2.76 | 2.35 | 2.32 | 2.72 | 2.76 | 2.51 | 2.32 | 2.36 | 2.38 | 2.56 | 1.99 | 1.81 | 1.79 | 2.74 | 2.62 | 2.52 | 2.44 | 2.55 | 2.61 | 4.01 | 2.43 |
| — | -6.4% | +0.1% | +15.3% | +16.2% | -1.7% | +16.8% | +30.7% | +33.1% | -6.8% | -24.2% | -28.4% | -26.9% | +7.7% | +0.4% | -37.1% | +0.5% | +20.7% | +17.3% | +29.3% | +7.2% | |
| Quick Ratio | 1.63 | 2.35 | 1.32 | 1.59 | 1.63 | 1.44 | 1.24 | 1.28 | 1.34 | 1.77 | 1.24 | 1.08 | 1.07 | 1.60 | 1.52 | 1.43 | 1.41 | 1.48 | 1.55 | 2.97 | 1.79 |
| — | +63.2% | +5.8% | +24.3% | +21.4% | -18.7% | +0.4% | +18.4% | +25.7% | +10.7% | -18.5% | -24.4% | -24.3% | +8.6% | -2.0% | -51.7% | -21.2% | -5.6% | -7.0% | +28.1% | +19.2% | |
| Interest Coverage | -6.99 | 0.52 | 3.74 | -9.01 | -43.54 | 1.41 | 1.08 | 1.21 | 2.62 | 1.38 | -0.68 | -1.29 | -0.27 | 1.44 | 1.51 | 1.10 | 0.65 | 0.91 | -1.83 | 0.64 | 1.32 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying PRGO stock.
Perrigo Company plc's current P/E is -1.2x. The average P/E over the last 1 quarters is 4.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Perrigo Company plc's current operating margin is 8.1%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Perrigo Company plc's business trajectory between earnings reports.